Chairman Kim Young-hoon says, “Commercialization of bio-innovative tech is urgent”
Daesung Group announced on Sept. 28 that it held the 2021 Daesung Haegang Microbes Forum at the Chosun Hotel in Seoul to look at the current and future possibilities of the bio sector.
At the forum held under the theme of " Microbial Efficiency for Sustainability: Carbon Neutrality and Global Pandemic-Addressing Fundamental Challenges," top scholars in the field of microorganisms introduced new microbial technologies to solve climate change and another infectious disease threatening humanity, and presented a new vision.
Marking its fourth anniversary this year, the Daeseong Haegang Microbes Forum was held in the form of an online and offline hybrid that broadcasts seminars such as lectures and discussions live online at the same time as on-site events.
The main speakers are Professor Lars Angenent of Tubingen University in Germany, a representative scientist of gas fermentation technology for the production of ▲ biomaterials and proteins ▲ Matthew Chang of National University of Singapore, who contributes to innovative medicine technology based on microbiome redesign and ▲ Kang Ji-hee, CEO of Atogen, a human microbiome therapeutics company.
Delivering welcoming remarks, Chairman Kim Young-hoon of Daesung Group, said, “As awareness of green growth is increasing and international environmental regulations strengthen, it seems inevitable that change will come to an economic paradigm based on fossil fuels.
“Commercialization of various bio-innovative technologies such as biofuels and biodegradable plastics is as critically urgent as the development of new vaccines.”
Stressing that microbial engineering will be the key to solving climate change and environmental issues, Chairman Kim said, “The transition to eco-friendly and renewable raw material-based biochemical industry will be fundamental to attaining sustainable growth and leadership in the new bioeconomy.”